NCT01946932

Brief Summary

This is a steering group approved substudy to the Target Temperature Management trial (TTM, ClinicalTrials.gov Identifier: NCT01020916). TTM compares the effect of two strictly controlled temperature regimes for survivors of out-of-hospital cardiac arrest. The primary aim of this sub-study is to compare the amount of cognitive impairment in cardiac arrest survivors treated with 33 degrees and 36 degrees and with a matched group of control patients with myocardial infarction. Our secondary aims are:

  • To investigate the impact of cognitive impairment on our patients' ability to participate in society and their health related quality of life.
  • To investigate the relationship between our patients cognitive impairments and their relatives/informants health related quality of life and feelings of burden.
  • To test the hypothesis that the simple cognitive screening battery used in the TTM main trial is sensitive enough to detect all patients with significant cognitive disability.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
287

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2011

Typical duration for not_applicable

Geographic Reach
5 countries

20 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

September 12, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 20, 2013

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

December 5, 2013

Status Verified

August 1, 2013

Enrollment Period

2.4 years

First QC Date

September 12, 2013

Last Update Submit

December 4, 2013

Conditions

Keywords

Induced hypothermiaMild induced hypothermiaResuscitationTherapeutic hypothermiaNeurological functionCardiovascular diseasesRehabilitationQuality of lifeCognition

Outcome Measures

Primary Outcomes (3)

  • Rivermead Behavioural Memory Test (RBMT)

    Memory test

    180 days after Cardiac Arrest (CA) or Myocardial Infarction (MI)

  • Frontal Assessment Battery (FAB)

    Screening of Executive functions

    180 days after CA or MI

  • Symbol Digit Modalities Test (SDMT)

    Assess attention, mental speed and concentration

    180 days after CA or MI

Secondary Outcomes (9)

  • Mayo-Portland Adaptability Inventory-4 (MPAI-4)

    180 days after CA or MI

  • Short-Form Questionnaire 36 version 2 (SF-36v2)

    180 days after CA or MI

  • Zarit Burden Interview

    180 days after CA or MI

  • Hospital Anxiety and Depression rating Scale (HADS)

    180 days after CA or MI

  • Two Simple Questions (TSQ)

    180 days after CA or MI

  • +4 more secondary outcomes

Study Arms (2)

Cardiac Arrest 33°

ACTIVE COMPARATOR

survivors with temperature treatment 33°

Other: Temperature treatment

Cardiac Arrest survivors 36°

ACTIVE COMPARATOR

survivors with temperature treatment 36°

Other: Temperature treatment

Interventions

Cardiac Arrest 33°Cardiac Arrest survivors 36°

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Out-of-Hospital Cardiac Arrest (OHCA)of presumed cardiac cause
  • Unconsciousness after sustained return of spontaneous circulation (ROSC)

You may not qualify if:

  • Known bleeding diathesis
  • Suspected or confirmed acute intracranial bleeding
  • Suspected or confirmed stroke
  • Unwitnessed asystole
  • Known limitations in therapy and Do Not Resuscitate-order
  • Known disease making 180 days survival unlikely
  • Known prearrest status Cerebral Performance Category (CPC)3 or 4
  • Temperature \<30°on admission
  • hours (240 minutes) from ROSC to screening
  • Systolic blood pressure \<80 mm Hg in spite of fluid loading/vasopressor and/or inotropic medication/intra aortic balloon pump
  • In-hospital cardiac arrest
  • OHCA of presumed non-cardiac arrest cause
  • Disability to speak the site language well enough to complete tests without interpreter
  • Controls should never have suffered a cardiac arrest

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (20)

Rigshospitalet

Copenhagen, Denmark

Location

San Martino Hospital

Genova, Italy

Location

Santa Maria degli Angeli Hospital

Pordenone, Italy

Location

Ospedale Universitario di Cattinaria

Trieste, Italy

Location

Academisch Medisch Centrum (AMC)

Amsterdam, Netherlands

Location

Onze Lieve Vrouwe Gasthuis

Amsterdam, Netherlands

Location

Rijnstate Hospital

Arnhem, Netherlands

Location

Leeuwarden Hospital

Leeuwarden, Netherlands

Location

Sahlgrenska University Hospital, Thorax

Gothenburg, Sweden

Location

Sahlgrenska University Hospital, Östra

Gothenburg, Sweden

Location

Sahlgrenska University Hospital

Gothenburg, Sweden

Location

Helsingborg Hospital

Helsingborg, Sweden

Location

Karlstad Central Hospital

Karlstad, Sweden

Location

Skåne University Hospital, Lund

Lund, Sweden

Location

Skåne University Hospital, Malmö

Malmo, Sweden

Location

Örebro University Hospital

Örebro, Sweden

Location

Royal Bournemouth Hospital

Bournemouth, United Kingdom

Location

University Hospital of Wales

Cardiff, United Kingdom

Location

St Georges' Hospital

London, United Kingdom

Location

Royal Berkshire NHS Foundation Trust

Reading, United Kingdom

Location

Related Publications (7)

  • Cronberg T, Lilja G, Rundgren M, Friberg H, Widner H. Long-term neurological outcome after cardiac arrest and therapeutic hypothermia. Resuscitation. 2009 Oct;80(10):1119-23. doi: 10.1016/j.resuscitation.2009.06.021. Epub 2009 Jul 23.

    PMID: 19631442BACKGROUND
  • Nielsen N, Wetterslev J, al-Subaie N, Andersson B, Bro-Jeppesen J, Bishop G, Brunetti I, Cranshaw J, Cronberg T, Edqvist K, Erlinge D, Gasche Y, Glover G, Hassager C, Horn J, Hovdenes J, Johnsson J, Kjaergaard J, Kuiper M, Langorgen J, Macken L, Martinell L, Martner P, Pellis T, Pelosi P, Petersen P, Persson S, Rundgren M, Saxena M, Svensson R, Stammet P, Thoren A, Unden J, Walden A, Wallskog J, Wanscher M, Wise MP, Wyon N, Aneman A, Friberg H. Target Temperature Management after out-of-hospital cardiac arrest--a randomized, parallel-group, assessor-blinded clinical trial--rationale and design. Am Heart J. 2012 Apr;163(4):541-8. doi: 10.1016/j.ahj.2012.01.013.

    PMID: 22520518BACKGROUND
  • Heimburg K, Cronberg T, Tornberg AB, Ullen S, Friberg H, Nielsen N, Hassager C, Horn J, Kjaergaard J, Kuiper M, Rylander C, Wise MP, Lilja G. Self-reported limitations in physical function are common 6 months after out-of-hospital cardiac arrest. Resusc Plus. 2022 Jul 19;11:100275. doi: 10.1016/j.resplu.2022.100275. eCollection 2022 Sep.

  • Lilja G, Nielsen N, Bro-Jeppesen J, Dunford H, Friberg H, Hofgren C, Horn J, Insorsi A, Kjaergaard J, Nilsson F, Pelosi P, Winters T, Wise MP, Cronberg T. Return to Work and Participation in Society After Out-of-Hospital Cardiac Arrest. Circ Cardiovasc Qual Outcomes. 2018 Jan;11(1):e003566. doi: 10.1161/CIRCOUTCOMES.117.003566.

  • Lilja G, Nilsson G, Nielsen N, Friberg H, Hassager C, Koopmans M, Kuiper M, Martini A, Mellinghoff J, Pelosi P, Wanscher M, Wise MP, Ostman I, Cronberg T. Anxiety and depression among out-of-hospital cardiac arrest survivors. Resuscitation. 2015 Dec;97:68-75. doi: 10.1016/j.resuscitation.2015.09.389. Epub 2015 Oct 9.

  • Lilja G, Nielsen N, Friberg H, Horn J, Kjaergaard J, Nilsson F, Pellis T, Wetterslev J, Wise MP, Bosch F, Bro-Jeppesen J, Brunetti I, Buratti AF, Hassager C, Hofgren C, Insorsi A, Kuiper M, Martini A, Palmer N, Rundgren M, Rylander C, van der Veen A, Wanscher M, Watkins H, Cronberg T. Cognitive function in survivors of out-of-hospital cardiac arrest after target temperature management at 33 degrees C versus 36 degrees C. Circulation. 2015 Apr 14;131(15):1340-9. doi: 10.1161/CIRCULATIONAHA.114.014414. Epub 2015 Feb 13.

  • Lilja G, Nielsen N, Friberg H, Horn J, Kjaergaard J, Pellis T, Rundgren M, Wetterslev J, Wise MP, Nilsson F, Cronberg T. Cognitive function after cardiac arrest and temperature management; rationale and description of a sub-study in the Target Temperature Management trial. BMC Cardiovasc Disord. 2013 Oct 12;13:85. doi: 10.1186/1471-2261-13-85.

MeSH Terms

Conditions

Heart ArrestOut-of-Hospital Cardiac ArrestCognition DisordersBrain InjuriesCardiovascular Diseases

Condition Hierarchy (Ancestors)

Heart DiseasesNeurocognitive DisordersMental DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Tobias Cronberg, MD, PhD

    Department of Clinical Sciences, Lund University, Lund, Sweden and Department of Neurology, Skåne University Hospital, Lund, Sweden

    STUDY CHAIR
  • Niklas Nielsen, MD,PhD

    Department of Clinical Sciences, Lund University, Lund Sweden and Department of Anesthesia and Intensive Care, Helsingborg Hospital, Helsingborg, Sweden

    PRINCIPAL INVESTIGATOR
  • Jesper Kjaergaard, MD, PhD

    The Heart Centrem Copenhagen University, Copenhagen, Denmark

    PRINCIPAL INVESTIGATOR
  • Janneke Horn, MD, PhD

    Department of Intensive Care, Academic Medical Centrum, Amsterdam, Netherlands

    PRINCIPAL INVESTIGATOR
  • Tommaso Pellis, MD, PhD

    Intensive Care Unit Santa Maria Degli Angeli, Pordenonde, Italy

    PRINCIPAL INVESTIGATOR
  • Matthew P Wise, MD, PhD

    Adult Critical Care, University Hospital of Wales, Cardiff, Untied Kingdom

    PRINCIPAL INVESTIGATOR
  • Gisela Lilja, OT

    Lund University Hospital, Lund, Sweden

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2013

First Posted

September 20, 2013

Study Start

June 1, 2011

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

December 5, 2013

Record last verified: 2013-08

Locations